Related references
Note: Only part of the references are listed.A Prospective Randomized Controlled Study of Long-Term Combination Therapy Using Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis and Dyslipidemia
Kenichi Hosonuma et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Time to make the change from 'primary biliary cirrhosis' to 'primary biliary cholangitis'
Angela C. Cheung et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis
T. H. Karlsen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Fibrate treatment for primary biliary cirrhosis
Frans J. C. Cuperus et al.
CURRENT OPINION IN GASTROENTEROLOGY (2014)
Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study
Willem J. Lammers et al.
GASTROENTEROLOGY (2014)
Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid
Sabela Lens et al.
LIVER INTERNATIONAL (2014)
The Immunobiology and Pathophysiology of Primary Biliary Cirrhosis
Gideon M. Hirschfield et al.
Annual Review of Pathology-Mechanisms of Disease (2013)
Fibrates as Adjuvant Therapy for Chronic Cholestatic Liver Disease: Its Time Has Come
Nisanne S. Ghonem et al.
HEPATOLOGY (2013)
Early Biochemical Response to Ursodeoxycholic Acid and Long-Term Prognosis of Primary Biliary Cirrhosis: Results of a 14-Year Cohort Study
Li-Na Zhang et al.
HEPATOLOGY (2013)
Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
C. Levy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis
Teru Kumagi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Acute Cholestatic Hepatitis Probably due to Fenofibrate
Bernard Maroy
THERAPIE (2010)
Review article: nuclear receptors and liver disease - current understanding and new therapeutic implications
D. A. H. Elfaki et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Non-invasive evaluation of liver cirrhosis using ultrasound
N. Goyal et al.
CLINICAL RADIOLOGY (2009)
Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid
Edith M. M. Kuiper et al.
GASTROENTEROLOGY (2009)
Primary Biliary Cirrhosis
Keith D. Lindor et al.
HEPATOLOGY (2009)
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study
Shinji Iwasaki et al.
HEPATOLOGY RESEARCH (2008)
Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases
Michael Trauner et al.
WIENER MEDIZINISCHE WOCHENSCHRIFT (2008)
Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid
A Parés et al.
GASTROENTEROLOGY (2006)
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis
C Corpechot et al.
GASTROENTEROLOGY (2005)
Peroxisome proliferator-activated receptor (PPAR)-α:: A pharmacological target with a promising future
DH van Raalte et al.
PHARMACEUTICAL RESEARCH (2004)
Prospective randomized crossover trial of combination therapy with bezafibrate and UDCA for primary biliary cirrhosis
J Itakura et al.
HEPATOLOGY RESEARCH (2004)
The PPARs: From orphan receptors to drug discovery
TM Willson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
